Studies related to Depression and L-Carnitine

Acetyl-L-carnitine Reduces Depression And Improves Quality Of Life In Patients With Minimal Hepatic Encephalopathy

Effect Decrease
Values Beck. Mean and SD. Placebo: before 23.5 ± 2.6, after 21.3 ± 2.6. Carnitine: before 23.6 ± 2.8, after 18 ± 3.5
Trial Design Double blind
Trial Length n/a
Number of Subjects 67
Sex n/a
Notes for this study:
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.

Full details on all 7 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.